Chart 1.
“Bench-to-bedside” therapeutic development of SLM from preclinical models to phase 1 and 2 clinical trials in patients with advanced clear-cell renal cell carcinoma (ccRCC).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.